Pharmacological data science perspective on fatal incidents of morphine treatment

Area of Science:

• Forensic Toxicology
• Clinical Pharmacology
• Medicolegal Death Investigation

Background:

• Morphine analgesia is associated with drug-related deaths (0.3%-4%).
• Assessing morphine's causal role in death is challenging due to its pharmacokinetics, active metabolites (e.g., morphine-6-glucuronide), and lack of defined toxic dose/concentration.
• Dosing is individualized for pain relief, complicating retrospective analysis.

Purpose of the Study:

• To review reported deaths linked to morphine therapy.
• To analyze factors influencing morphine's role in mortality, including exposure and patient-specific variables (pharmacogenetics, medications, comorbidities).
• To evaluate the reliability of postmortem morphine concentrations for dose inference.

Main Methods:

• Systematic analysis of published data on morphine and metabolite concentrations in postmortem biological samples.
• Review of medicolegal cases involving disputed morphine causality.
• Application of pharmacokinetic modeling to estimate administered morphine doses.

Main Results:

• Inference of administered morphine dose from postmortem blood concentrations demonstrates low validity.
• Morphine's role in patient death is highly context-dependent.
• Establishing causality requires a collaborative assessment by multidisciplinary experts.

Conclusions:

• Postmortem morphine levels are unreliable indicators of administered dose.
• Determining morphine's causal link to death necessitates expert consensus considering numerous patient-specific factors.
• Accurate medicolegal death investigation requires nuanced interpretation beyond simple concentration thresholds.